Lemaitre Vascular Inc (LMAT) Files Form 4 Insider Selling : Trent G Kamke Sells 16,465 Shares

Lemaitre Vascular Inc (LMAT): Trent G Kamke , Senior V. P., Operations of Lemaitre Vascular Inc sold 16,465 shares on May 20, 2016. The Insider selling transaction was reported by the company on May 24, 2016 to the Securities and Exchange Commission. The shares were sold at $15.02 per share for a total value of $247,307.22 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on May 18, 2016, George W Lemaitre (Chairman and CEO) sold 2,944 shares at $15.17 per share price.On May 18, 2016, Trent G Kamke (Senior V. P., Operations) sold 2,400 shares at $15.46 per share price.Also, On May 9, 2016, David B Roberts (President and Director) sold 17,064 shares at $15.89 per share price.On Dec 14, 2015, Joseph P Jr Pellegrino (Chief Financial Officer) sold 21,033 shares at $16.01 per share price.

LeMaitre Vascular Inc: On Friday, May 20, 2016 heightened volatility was witnessed in LeMaitre Vascular Inc which led to swings in the share price. The shares opened for trading at $14.95 and hit $15.0799 on the upside , eventually ending the session at $14.99, with a gain of 0.67% or 0.1 points. The heightened volatility saw the trading volume jump to 41,526 shares. The 52-week high of the share price is $18.44 and the company has a market cap of $275,501 M . The 52-week low of the share price is at $9.53.

LeMaitre Vascular Inc Money Flow Index Chart

Company has been under the radar of several Street Analysts.LeMaitre Vascular Inc is Reiterated by Barrington Research to Outperform and the brokerage firm has raised the Price Target to $ 15.50 from a previous price target of $14 .The Rating was issued on Feb 25, 2016.

LeMaitre Vascular Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop manufacture and market medical devices and implants used primarily in the field of vascular surgery. The Company’s product lines include valvulotomes balloon catheters carotid shunts biologic patches biologic grafts radiopaque marking tape anastomotic clips remote endarterectomy devices laparoscopic cholecystectomy devices vascular grafts angioscopes and powered phlebectomy devices. The Company develops manufactures and markets vascular devices to address the needs of vascular surgeons. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart including the Expandable LeMaitre Valvulotome the Pruitt F3 Carotid Shunt VascuTape Radiopaque Tape and the XenoSure biologic patch.

Leave a Reply

LeMaitre Vascular Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on LeMaitre Vascular Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.